🇺🇸 FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10988441

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Valo Early Discovery, Inc. · Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10988450

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10981915

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. · Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10934299

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. · Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10927130

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-spe

Valo Early Discovery, Inc. · Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10913753

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Valo Early Discovery, Inc. · Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10906916

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. · Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10889592

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Valo Early Discovery, Inc. · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10874649

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10870645

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10836741

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829462

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829461

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829460

[6,6] fused bicyclic HDAC8 inhibitors

Valo Early Discovery, Inc. · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822316

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted